A simple and effective method to remove pigments from heterologous secretory proteins expressed in Pichia pastoris

Abstract

• High-level secretion expression (~250 mg L-1) of divalent nanobodies in Pichia.

• Detergent washing effectively removes yellow pigment from secreted nanobodies.

• Nanobodies after pigment removal remain biologically active.

Keywords

Detergent / Divalent nanobody / Lauryldimethylamine N-oxide / Neutralizing antibody / Pichia pigment / SARS-CoV-2 / Secretion expression / Spike receptor-binding domain / Synthetic nanobody

References

[1] Ahmad M, Hirz M, Pichler H, Schwab H. Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol, 2014, 98: 5301-5317,

[2] Arruda A, et al.. A constitutive expression system for Pichia pastoris based on the PGK1 promoter. Biotechnol Lett, 2016, 38: 509-517,

[3] Azadi S, et al.. Bioprocess and downstream optimization of recombinant human growth hormone in Pichia pastoris. Res Pharm Sci, 2018, 13: 222-238,

[4] Belew M, et al.. Purification of Recombinant Human Serum Albumin (rHSA) Produced by Genetically Modified Pichia Pastoris. Sep Sci Technol, 2008, 43: 3134-3153,

[5] Bos IG, et al.. Recombinant human C1-inhibitor produced in Pichia pastoris has the same inhibitory capacity as plasma C1-inhibitor. Biochim Biophys Acta, 2003, 1648: 75-83,

[6] Byrne B. Pichia pastoris as an expression host for membrane protein structural biology. Curr Opin Struct Biol, 2015, 32: 9-17,

[7] Cai H, et al.. An improved fluorescent tag and its nanobodies for membrane protein expression, stability assay, and purification. Commun Biol, 2020, 3: 753,

[8] Cai H, Yao H, Li T, Tang Y, Li D. High-level heterologous expression of the human transmembrane sterol Δ8, Δ7-isomerase in Pichia pastoris. Protein Expr Purif, 2019, 164: 105463,

[9] Cayetano-Cruz M, et al.. High level expression of a recombinant xylanase by Pichia pastoris cultured in a bioreactor with methanol as the sole carbon source: Purification and biochemical characterization of the enzyme. Biochem Eng J, 2016, 112: 161-169,

[10] Cereghino JL, Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev, 2000, 24: 45-66,

[11] Chang C-H, Hsiung H-A, Hong K-L, Huang C-T. Enhancing the efficiency of the Pichia pastoris AOX1 promoter via the synthetic positive feedback circuit of transcription factor Mxr1. BMC Biotechnol, 2018, 18: 81,

[12] Cregg JM, et al.. High-Level Expression and Efficient Assembly of Hepatitis B Surface Antigen in the Methylotrophic Yeast Pichia Pastoris. Bio/Technology, 1987, 5: 479-485

[13] Farnós O, et al.. High-level expression and immunogenic properties of the recombinant rabbit hemorrhagic disease virus VP60 capsid protein obtained in Pichia pastoris. J Biotechnol, 2005, 117: 215-224,

[14] Files D, Ogawa M, Scaman CH, Baldwin SA. A Pichia pastoris fermentation process for producing high-levels of recombinant human cystatin-C. Enzyme Microb Technol, 2001, 29: 335-340,

[15] Guerrero-Olazarán M, Rodríguez-Blanco L, Carreon-Treviño JG, Gallegos-López JA, Viader-Salvadó JM. Expression of a Bacillus Phytase C Gene in Pichia pastoris and Properties of the Recombinant Enzyme. Appl Environ Microbiol, 2010, 76: 5601-5608,

[16] Juturu V, Wu JC. Heterologous Protein Expression in Pichia pastoris: Latest Research Progress and Applications. ChemBioChem, 2018, 19: 7-21,

[17] Karim KMR, et al.. Characterization and expression in Pichia pastoris of a raw starch degrading glucoamylase (GA2) derived from Aspergillus flavus NSH9. Protein Expr Purif, 2019, 164,

[18] Katla S, et al.. High level extracellular production of recombinant human interferon alpha 2b in glycoengineered Pichia pastoris: culture medium optimization, high cell density cultivation and biological characterization. J Appl Microbiol, 2019, 126: 1438-1453,

[19] Kim S-I, Wu Y, Kim K-L, Kim G-J, Shin H-J. Improved cell disruption of Pichia pastoris utilizing aminopropyl magnesium phyllosilicate (AMP) clay. World J Microbiol Biotechnol, 2013, 29: 1129-1132,

[20] Krainer FW, et al.. Recombinant protein expression in Pichia pastoris strains with an engineered methanol utilization pathway. Microbial Cell Factories, 2012, 11: 22,

[21] Li S, et al.. A novel purification procedure for recombinant human serum albumin expressed in Pichia pastoris. Protein Expr Purif, 2018, 149: 37-42,

[22] Li T, et al.. A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection. Nat Commun, 2020, 12: 4635,

[23] Li T, et al.. Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody. EMBO Mol Med, 2021, 13: e14544,

[24] Li T, et al.. Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants. Front Microbiol, 2022, 13: 875840,

[25] Li T, et al.. Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2. Int J Biol Macromol, 2022, 209: 1379-1388,

[26] Lin-Cereghino GP, et al.. The effect of α-mating factor secretion signal mutations on recombinant protein expression in Pichia pastoris. Gene, 2013, 519: 311-317,

[27] Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM. Heterologous protein production using the Pichia pastoris expression system. Yeast, 2005, 22: 249-270,

[28] Mallem M, et al.. Maximizing recombinant human serum albumin production in a Muts Pichia pastoris strain. Biotechnol Prog, 2014, 30: 1488-1496,

[29] Marx H, Mecklenbräuker A, Gasser B, Sauer M, Mattanovich D. Directed gene copy number amplification in Pichia pastoris by vector integration into the ribosomal DNA locus. FEMS Yeast Res, 2009, 9: 1260-1270,

[30] Matthews CB, Kuo A, Love KR, Love JC. Development of a general defined medium for Pichia pastoris. Biotechnol Bioeng, 2018, 115: 103-113,

[31] Minning S, Schmidt-Dannert C, Schmid RD. Functional expression of Rhizopus oryzae lipase in Pichia pastoris: high-level production and some properties. J Biotechnol, 1998, 66: 147-156,

[32] Moore BD, Deere J, Edrada-Ebel R, Ingram A, van der Walle CF. Isolation of recombinant proteins from culture broth by co-precipitation with an amino acid carrier to form stable dry powders. Biotechnol Bioeng, 2010, 106: 764-773,

[33] Nagai N, et al.. Recombinant human microplasmin: production and potential therapeutic properties. J Thromb Haemost, 2003, 1: 307-313,

[34] Nokelainen M, et al.. High-level production of human type I collagen in the yeast Pichia pastoris. Yeast, 2001, 18: 797-806,

[35] Polez S, et al.. A Simplified and Efficient Process for Insulin Production in Pichia pastoris. PLoS One, 2016, 11: e0167207,

[36] Radulescu A, Zorko NA, Yu X, Besner GE. Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis. Pediatr Res, 2009, 65: 437-442,

[37] Razdan S, Wang J-C, Barua S. PolyBall: A new adsorbent for the efficient removal of endotoxin from biopharmaceuticals. Sci Rep, 2019, 9: 8867,

[38] Romanos M. Advances in the use of Pichia pastoris for high-level gene expression. Curr Opin Biotechnol, 1995, 6: 527-533,

[39] Rosenfeld SA, et al.. Production and purification of recombinant hirudin expressed in the methylotrophic yeast Pichia pastoris. Protein Expr Purif, 1996, 8: 476-482,

[40] Shu M, et al.. Expression, activation and characterization of porcine trypsin in Pichia pastoris GS115. Protein Expr Purif, 2015, 114: 149-155,

[41] Shukla R, et al.. Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo. Front Microbiol, 2017, 8: 2644,

[42] Spadiut O, Capone S, Krainer F, Glieder A, Herwig C. Microbials for the production of monoclonal antibodies and antibody fragments. Trends Biotechnol, 2014, 32: 54-60,

[43] Sreekrishna K, et al.. High level expression of heterologous proteins in methylotrophic yeast Pichia pastoris. J Basic Microbiol, 1988, 28: 265-278,

[44] Steglich M, et al.. Expression, purification and initial characterization of human serum albumin domain I and its cysteine 34. PLoS One, 2020, 15: e0240580,

[45] Van Roy M, et al.. The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis. Arthritis Res Ther, 2015, 17: 135,

[46] Wood MJ, Komives EA. Production of large quantities of isotopically labeled protein in Pichia pastoris by fermentation. J Biomol NMR, 1999, 13: 149-159,

[47] Xiong AS, et al.. High level expression of a recombinant acid phytase gene in Pichia pastoris. J Appl Microbiol, 2005, 98: 418-428,

[48] Xu N, et al.. Identification and characterization of novel promoters for recombinant protein production in yeast Pichia pastoris. Yeast, 2018, 35: 379-385,

[49] Yao H, et al.. A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2. PLoS Pathog, 2020, 17: e1009328,

[50] Yu KM, et al.. Efficient expression and isolation of recombinant human interleukin-11 (rhIL-11) in Pichia pastoris. Protein Expr Purif, 2018, 146: 69-77,

[51] Zhao W, et al.. High Level Expression of an Acid-Stable Phytase from Citrobacter freundii in Pichia pastoris. Appl Biochem Biotechnol, 2010, 162: 2157-2165,

[52] Higgins DR. Overview of protein expression in Pichia pastoris. Curr Protoc Protein Sci Chapter 5, Unit5.7 (2001).

Funding

National Natural Science Foundation of China(82151215)

the Strategic Priority Research Program of CAS(XDB37020204)

Science and Technology Commission of Shanghai Municipality(22ZR1468300)